Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Zain

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Cancers|May 27, 2026
Primary Cutaneous Anaplastic Large Cell Lymphoma: A Review of Diagnosis and Treatment for the General OncologistJackson T Bowers, Jasmine Zain
Current Hematologic Malignancy Reports|October 10, 2022
Circulating Tumor DNA in LymphomaSwetha Kambhampati Thiruvengadam, Jasmine Zain
Leukemia & Lymphoma|June 17, 2024
Experience of using venetoclax in relapsed T- cell lymphomaJasmine Zain, Matthew Lunning, Steven Rosen
Journal of Hematology & Oncology|May 19, 2012
Novel therapeutic agents for cutaneous T-Cell lymphomaSalvia Jain, Jasmine Zain, Owen O'Connor
Expert Review of Hematology|November 19, 2010
Emerging role of epigenetic therapies in cutaneous T-cell  lymphomasJasmine Zain, David Kaminetzky, Owen A O'Connor
Cancer Treatment and Research|January 1, 2019
Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary SyndromeChristiane Querfeld, Jasmine Zain, Steven T Rosen
JAMA Network Open|May 27, 2021
Autologous vs Allogeneic Hematopoietic Cell Transplantation for Patients With Peripheral T-cell Lymphomas-Closer, Yet Still So Far to GoJoseph C Alvarnas, Ann Vanderplas, Jasmine Zain
JAMA Oncology|July 17, 2015
Lesion on the Plantar Foot. ShinglesTimothy H Almazan, Jasmine Zain, Jae Y Jung
Core Evidence|June 10, 2011
Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myelomaSalvia Jain, Catherine Diefenbach, Jasmine Zain, et al.
Expert Opinion on Emerging Drugs|March 2, 2022
Emerging drugs for the treatment of cutaneous T-cell lymphomaMelissa Cheng, Jasmine Zain, Steven T Rosen, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Cancers|May 27, 2026
Primary Cutaneous Anaplastic Large Cell Lymphoma: A Review of Diagnosis and Treatment for the General OncologistJackson T Bowers, Jasmine Zain
Current Hematologic Malignancy Reports|October 10, 2022
Circulating Tumor DNA in LymphomaSwetha Kambhampati Thiruvengadam, Jasmine Zain
Leukemia & Lymphoma|June 17, 2024
Experience of using venetoclax in relapsed T- cell lymphomaJasmine Zain, Matthew Lunning, Steven Rosen
Journal of Hematology & Oncology|May 19, 2012
Novel therapeutic agents for cutaneous T-Cell lymphomaSalvia Jain, Jasmine Zain, Owen O'Connor
Expert Review of Hematology|November 19, 2010
Emerging role of epigenetic therapies in cutaneous T-cell  lymphomasJasmine Zain, David Kaminetzky, Owen A O'Connor
Cancer Treatment and Research|January 1, 2019
Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary SyndromeChristiane Querfeld, Jasmine Zain, Steven T Rosen
JAMA Network Open|May 27, 2021
Autologous vs Allogeneic Hematopoietic Cell Transplantation for Patients With Peripheral T-cell Lymphomas-Closer, Yet Still So Far to GoJoseph C Alvarnas, Ann Vanderplas, Jasmine Zain
JAMA Oncology|July 17, 2015
Lesion on the Plantar Foot. ShinglesTimothy H Almazan, Jasmine Zain, Jae Y Jung
Core Evidence|June 10, 2011
Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myelomaSalvia Jain, Catherine Diefenbach, Jasmine Zain, et al.
Expert Opinion on Emerging Drugs|March 2, 2022
Emerging drugs for the treatment of cutaneous T-cell lymphomaMelissa Cheng, Jasmine Zain, Steven T Rosen, et al.
Pageof 12